Beta Bionics, Inc.
BBNX· Nasdaq
BBNXBeta Bionics, Inc.
Filed Feb 24, 2026 · 10-K · 55 days after period end · 0001193125-26-067065
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures |
|---|---|---|
| Revenue | $32.12M | $20.44M |
| Net Income | -$13.47M | -$18.11M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Beta Bionics, Inc. · CIK 1674632 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 24, 2026 · 55 d after period end
